RSM advises on sale to NASDAQ listed company

RSM has advised on the sale of Medical Equipment Supplies and Management, to NASDAQ listed global laboratory supplier and distributor.

Based in Chorley, Medical Equipment Supplies and Management (MESM) provides medical equipment solutions for the clinical trials industry - supporting patients across the UK and globally.

The RSM team, including James Wild, Nick Wyatt and Matt Ritchie, acted for the shareholders of MESM on the transaction. Turner Parkinson provided legal support to the shareholders with corporate partners David Easdown and James Sheridan advising with assistance from David Hayes, Ryan Tweedale and Matthew Hitchen.

James Wild, corporate finance partner at RSM, said:

‘The deal brings together two complementary businesses delivering key synergies, increased commercial opportunities and access to new markets to support the growth plan for MESM.’